VivoSim Labs, INC. (VIVS)

↓ Download CSV

CIK 0001497253 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Mar 31

In fiscal 2026, VivoSim Labs, INC. reported revenue of $131.0K, down 9.0% from the prior year. The company ran a net loss, with a net margin of -10567.2%. It held $7.39M in total assets against $8.48M in total liabilities.

Key ratios (FY2026)

-8768.7%
Operating margin
-10567.2%
Net margin
-9.0%
Revenue growth (YoY)
Metric (FY)2026202520242023202220212020201920182017
Revenue$131.0K$144.0K$109.0K$370.0K$1.50M$0$2.20M$3.09M$4.60M
Cost of Revenue$0$5.0K$0$328.0K$482.0K$1.03M
Operating Income-$11.49M-$12.62M-$15.09M-$17.73M-$11.48M-$16.83M-$21.48M-$27.27M-$35.27M-$38.58M
Net Income-$13.84M-$2.49M-$14.67M-$17.26M-$11.45M-$16.83M-$18.71M-$26.64M-$34.80M-$38.45M
EPS (Diluted)$-5.35$-1.70$-19.25$-1.98$-1.32
Total Assets$7.39M$14.65M$6.35M$20.31M$33.30M$39.92M$28.44M$40.62M$49.83M$69.18M
Total Liabilities$8.48M$4.16M$2.75M$4.98M$3.09M$721.0K$1.81M$4.33M$5.24M$6.82M
Shareholders' Equity-$1.10M$10.49M$3.60M$15.33M$30.21M$39.20M$26.63M$36.30M$44.59M$62.36M
Cash & Equivalents$5.02M$11.31M$2.90M$15.30M$28.68M$37.36M$27.36M$36.48M$43.73M$62.75M
Operating Cash Flow-$10.83M-$9.46M-$14.65M-$12.41M-$8.45M-$13.32M-$14.88M-$20.38M-$28.86M
Capital Expenditures$0$13.0K$42.0K$396.0K$409.0K$405.0K$0$79.0K$226.0K$1.35M
Shares Outstanding2.89M1.90M839.8K8.72M8.71M8.67M6.53M124.02M111.03M104.55M